Th1/Th2 Cytokine Ratio in Tissue Transudates from Patients with Oral Lichen Planus

Rhodus, Nelson L.; Cheng, Bin; Ondrey, Frank

doi:https://doi.org/10.1155/2007/19854

Mediators of Inflammation

On this page

Abstract References Copyright Related Articles

Clinical Study | Open Access

Volume 2007 | Article ID 019854 | https://doi.org/10.1155/2007/19854

Th1/Th2 Cytokine Ratio in Tissue Transudates from Patients with Oral Lichen Planus

Nelson L. Rhodus,^1,3Bin Cheng,²and Frank Ondrey³

Received12 Sept 2006

Revised17 Dec 2006

Accepted17 Dec 2006

Published07 Feb 2007

Abstract

Objective. The characteristics of oral lichen planus (OLP) provoke investigators to explore possible biomarkers by which to monitor disease activity and therapeutic efficacy. Oral fluids may provide an accessible medium for analysis of such biomarkers. Previous studies have shown that activation of nuclear factor-kappa B (NF-κ B) plays an important role in the pathogenesis of oral lichen planus (OLP), which is a chronic inflammatory disorder mediated by T cells. Prior to the present investigation, reports of the levels of NF-κ B and its dependent cytokines in oral fluids have not been forthcoming. The purpose of this study was to detect the level of NF-κ B dependent cytokines, TNF-alpha, IL-1-alpha, IL-6, and IL-8 in tissue transudates directly from lesions of OLP, and explore the feasibility of the data for clinical application. Study design. Thirteen definitively diagnosed OLP subjects were enrolled in the study as were 13 age-sex matched controls. In each subject, lesion tissue transudates (TTs) were collected by a novel collection technique with a filter paper. The level of cytokines, TNF-alpha, IL-1-alpha, IL-6, and IL-8 in three types of oral fluids were determined by ELISA. Results. In the tissue transudate(TT), there were significantly higher level of cytokines TNF-alpha, IL-1-alpha, IL-6, and IL-8 detected in OLP patients than in controls: (TT: 40.0±9.8 versus 4.5±0.7, 710±114 versus 305±78, 150±25 versus 1.7±0.5, 2800±260 versus 1450±130, P<.0001; unit: pg/mL). Conclusions. These results indicate that NF-κ B dependent inflammatory cytokines may be detected at increased levels in oral lesion tissue transudates which may have diagnostic and prognostic potentials for monitoring disease activity and making therapeutic decisions in patients with OLP.

References

J. Rengarajan, S. J. Szabo, and L. H. Glimcher, “Transcriptional regulation of Th1/Th2 polarization,” Immunology Today, vol. 21, no. 10, pp. 479–483, 2000.
View at: Publisher Site | Google Scholar
D. O. Gor, N. R. Rose, and N. S. Greenspan, “ $T_{H} 1 - T_{H} 2$ : a procrustean paradigm,” Nature Immunology, vol. 4, no. 6, pp. 503–505, 2003.
View at: Publisher Site | Google Scholar
K. Hamzaoui, A. Hamzaoui, F. Guemira, M. Bessioud, M. Hamza, and K. Ayed, “Cytokine profile in Behçet's disease patients: relationship with disease activity,” Scandinavian Journal of Rheumatology, vol. 31, no. 4, pp. 205–210, 2002.
View at: Publisher Site | Google Scholar
M. Ramos-Casals, M. García-Carrasco, R. Cervera et al., “Th1/Th2 cytokine imbalance in patients with Sjögren syndrome secondary to hepatitis C virus infection,” Seminars in Arthritis and Rheumatism, vol. 32, no. 1, pp. 56–63, 2002.
View at: Publisher Site | Google Scholar
K. Ghoreschi, U. Mrowietz, and M. Röcken, “A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses,” Journal of Molecular Medicine, vol. 81, no. 8, pp. 471–480, 2003.
View at: Publisher Site | Google Scholar
K. Ghoreschi, P. Thomas, S. Breit et al., “Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease,” Nature Medicine, vol. 9, no. 1, pp. 40–46, 2003.
View at: Publisher Site | Google Scholar
D. Pohlers, K. Nissler, O. Frey et al., “Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation,” Clinical and Experimental Immunology, vol. 135, no. 3, pp. 409–415, 2004.
View at: Publisher Site | Google Scholar
H.-U. Simon, H. Seelbach, R. Ehmann, and M. Schmitz, “Clinical and immunological effects of low-dose IFN- $α$ treatment in patients with corticosteroid-resistant asthma,” Allergy, vol. 58, no. 12, pp. 1250–1255, 2003.
View at: Publisher Site | Google Scholar
C. Simark-Mattsson, G. Bergenholtz, M. Jontell et al., “Distribution of interleukin-2, -4, -10, tumour necrosis factor- $a$ and transforming growth factor- $ß$ mRNAs in oral lichen planus,” Archives of Oral Biology, vol. 44, no. 6, pp. 499–507, 1999.
View at: Publisher Site | Google Scholar
F. Chiappelli, M. A. Kung, P. Nguyen, P. Villanueva, E. A. Farhadian, and L. R. Eversole, “Cellular immune correlates of clinical severity in oral lichen planus: preliminary association with mood states,” Oral Diseases, vol. 3, no. 2, pp. 64–70, 1997.
View at: Google Scholar
E. E. Karagouni, E. N. Dotsika, and A. Sklavounou, “Alteration in peripheral blood mononuclear cell function and serum cytokines in oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 23, no. 1, pp. 28–35, 1994.
View at: Publisher Site | Google Scholar
A. Khan, C. S. Farah, N. W. Savage, L. J. Walsh, D. J. Harbrow, and P. B. Sugerman, “Th1 cytokines in oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 32, no. 2, pp. 77–83, 2003.
View at: Publisher Site | Google Scholar
A. Fayyazi, S. Schweyer, A. Soruri et al., “T lymphocytes and altered keratinocytes express interferon- $?$ and interleukin 6 in lichen planus,” Archives of Dermatological Research, vol. 291, no. 9, pp. 485–490, 1999.
View at: Publisher Site | Google Scholar
C. Simark-Mattsson, M. Jontell, G. Bergenholtz, M. Heyden, and U. I. Dahlgren, “Distribution of interferon- $γ$ mRNA-positive cells in oral lichen planus lesions,” Journal of Oral Pathology and Medicine, vol. 27, no. 10, pp. 483–488, 1998.
View at: Google Scholar
S. Pezelj-Ribaric, I. B. Prso, M. Abram, I. Glazar, G. Brumini, and M. Simunovic-Soskic, “Salivary levels of tumor necrosis factor- $α$ in oral lichen planus,” Mediators of Inflammation, vol. 13, no. 2, pp. 131–133, 2004.
View at: Publisher Site | Google Scholar
A. Sklavounou, E. Chrysomali, A. Scorilas, and A. Karameris, “TNF- $α$ expression and apoptosis-regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation,” Journal of Oral Pathology and Medicine, vol. 29, no. 8, pp. 370–375, 2000.
View at: Publisher Site | Google Scholar
T. Yamamoto, T. Osaki, K. Yoneda, and E. Ueta, “Cytokine production by keratinocytes and mononuclear infiltrates in oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 23, no. 7, pp. 309–315, 1994.
View at: Publisher Site | Google Scholar
T. Yamamoto and T. Osaki, “Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus,” Journal of Investigative Dermatology, vol. 104, no. 5, pp. 784–788, 1995.
View at: Publisher Site | Google Scholar
A. Sun, J.-S. Chia, Y.-F. Chang, and C.-P. Chiang, “Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 31, no. 4, pp. 196–203, 2002.
View at: Publisher Site | Google Scholar
A. Karatsaidis, O. Schreurs, T. Axéll, K. Helgeland, and K. Schenck, “Inhibition of the transforming growth factor- $β$ /Smad signaling pathway in the epithelium of oral lichen,” Journal of Investigative Dermatology, vol. 121, no. 6, pp. 1283–1290, 2003.
View at: Publisher Site | Google Scholar
M. Zehnder, J. S. Greenspan, D. Greenspan, and M. Bickel, “Chemokine gene expression in human oral mucosa,” European Journal of Oral Sciences, vol. 107, no. 4, pp. 231–235, 1999.
View at: Publisher Site | Google Scholar
M. C. Little, C. E. M. Griffiths, R. E. B. Watson, M. N. Pemberton, and M. H. Thornhill, “Oral mucosal keratinocytes express RANTES and ICAM-1, but not interleukin-8, in oral lichen planus and oral lichenoid reactions induced by amalgam fillings,” Clinical and Experimental Dermatology, vol. 28, no. 1, pp. 64–69, 2003.
View at: Publisher Site | Google Scholar
P. B. Sugerman, N. W. Savage, L. J. Walsh et al., “The pathogenesis of oral lichen planus,” Critical Reviews in Oral Biology and Medicine, vol. 13, no. 4, pp. 350–365, 2002.
View at: Google Scholar
J. W. Little, D. A. Falace, C. S. Miller, and N. L. Rhodus, Eds., Dental Management of the Medically Compromised Patient, Mosby, Saint Louis, Mo, USA, 6th edition, 2002.
N. L. Rhodus, L. Dahmer, K. Lindemann, J. Rudney, A. Mathur, and J. Bereuter, “s-IgA and cytokine levels in whole saliva of Sjögren's syndrome patients before and after oral pilocarpine hydrochloride administration: a pilot study,” Clinical Oral Investigations, vol. 2, no. 4, pp. 191–196, 1998.
View at: Publisher Site | Google Scholar
F. Ondrey, G. Dong, J. Sunwoo et al., “Constitutive activation of transcription factors NF- $?$ B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines,” Molecular Carcinogenesis, vol. 26, no. 2, pp. 119–129, 1999.
View at: Publisher Site | Google Scholar
I. Krause, G. Valesini, R. Scrivo, and Y. Shoenfeld, “Autoimmune aspects of cytokine and anticytokine therapies,” American Journal of Medicine, vol. 115, no. 5, pp. 390–397, 2003.
View at: Publisher Site | Google Scholar
M. Voulgarelis, S. Giannouli, D. Anagnostou, and A. G. Tzioufas, “Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas,” Rheumatology, vol. 43, no. 8, pp. 1050–1053, 2004.
View at: Publisher Site | Google Scholar
M. M. Zandbelt, P. C. M. de Wilde, P. A. van Damme, C. B. Hoyng, L. B. A. van de Putte, and F. H. J. van den Hoogen, “Etanercept in the treatment of patients with primary Sjögren's syndrome: a pilot study,” Journal of Rheumatology, vol. 31, no. 1, pp. 96–101, 2004.
View at: Google Scholar
S. Diehl and M. Rincón, “The two faces of IL-6 on Th1/Th2 differentiation,” Molecular Immunology, vol. 39, no. 9, pp. 531–536, 2002.
View at: Publisher Site | Google Scholar
S. Babu and T. B. Nutman, “Proinflammatory cytokines dominate the early immune response to filarial parasites,” Journal of Immunology, vol. 171, no. 12, pp. 6723–6732, 2003.
View at: Google Scholar
T. Yamamoto, K. Yoneda, E. Ueta, and T. Osaki, “Serum cytokines, interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in oral disorders,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 78, no. 6, pp. 727–735, 1994.
View at: Publisher Site | Google Scholar
U. Costabel and J. Guzman, “Bronchoalveolar lavage in interstitial lung disease,” Current Opinion in Pulmonary Medicine, vol. 7, no. 5, pp. 255–261, 2001.
View at: Publisher Site | Google Scholar
L. Liu, N. N. Jarjour, W. W. Busse, and E. A. B. Kelly, “Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 10, pp. 1118–1124, 2004.
View at: Publisher Site | Google Scholar
F. Saint, N. Kurth, P. Maille et al., “Urinary IL-2 assay for monitoring intravesical bacillus Calmette-Guérin response of superficial bladder cancer during induction course and maintenance therapy,” International Journal of Cancer, vol. 107, no. 3, pp. 434–440, 2003.
View at: Publisher Site | Google Scholar
S.-H. Park, D.-J. Min, M.-L. Cho et al., “Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 44, no. 3, pp. 561–569, 2001.
View at: Publisher Site | Google Scholar
K. Kaneyama, N. Segami, J. Sato, M. Nishimura, and H. Yoshimura, “Interleukin-6 family of cytokines as biochemical markers of osseous changes in the temporomandibular joint disorders,” British Journal of Oral and Maxillofacial Surgery, vol. 42, no. 3, pp. 246–250, 2004.
View at: Publisher Site | Google Scholar
P. Sfriso, P. A. Ostuni, C. Botsios et al., “Serum and salivary neopterin and interferon- $?$ in primary Sjögren's syndrome: correlation with clinical, laboratory and histopathologic features,” Scandinavian Journal of Rheumatology, vol. 32, no. 2, pp. 74–78, 2003.
View at: Publisher Site | Google Scholar
S. Ruhl, S. Homberaer, R. Betz et al., “Salivary proteins and cytokines in drug-induced gingival overgrowth,” Journal of Dental Research, vol. 83, no. 4, pp. 322–326, 2004.
View at: Google Scholar

Copyright

Copyright © 2007 Nelson L. Rhodus et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation Order printed copies

Views

561

Downloads

1198

Citations